SCHEMBL4403897

SCHEMBL4403897

CCCCc1ccc[n+](CCCc2cccc(CCC[n+]3cccc(CCCC)c3)c2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.48
CHRNA7 P36544 3/20 0.48
CHRNA10 Q9GZZ6 3/20 0.48
CHRNA9 Q9UGM1 3/20 0.48
HDAC4 P56524 1/20 0.47
APAF1 O14727 2/20 0.46
MAPT P10636 2/20 0.46
LMNA P02545 2/20 0.46
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
POLB P06746 1/20 0.46
RAD52 P43351 1/20 0.46
BLM P54132 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
GGPS1 O95749 2/20 0.43
THRB P10828 1/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13267940 0.95 CHRNA7 (0.53) HDAC1CHRNA7CHRNA10CHRNA9HDAC4
SCHEMBL5298519 0.90 HDAC1 (0.53) HDAC1HDAC4APAF1LMNAALDH1A1
SCHEMBL12638121 0.89 CHRNA7 (0.61) HDAC1CHRNA7CHRNA10CHRNA9HDAC4
SCHEMBL5305648 0.89 CHRNA7 (0.49) HDAC1CHRNA7CHRNA10CHRNA9HDAC4
SCHEMBL5290862 0.88 HDAC1 (0.55) HDAC1HDAC4APAF1LMNAALDH1A1
Hydrochloric Acid SCHEMBL30330313 0.88 HDAC1 (0.55) HDAC1HDAC4APAF1MAPTLMNA
Water SCHEMBL30259465 0.88 HDAC1 (0.55) HDAC1CHRNA7CHRNA10CHRNA9HDAC4
SCHEMBL5294637 0.87 HDAC1 (0.57) HDAC1HDAC4APAF1LMNAALDH1A1
SCHEMBL5302832 0.87 HDAC1 (0.57) HDAC1HDAC4APAF1LMNAALDH1A1
SCHEMBL5301408 0.87 HDAC1 (0.57) HDAC1HDAC4APAF1LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178678-B2 Bis-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2012-05-15 US disclosed
US-20100069432-A1 Bis-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2010-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069432-A1 Bis-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors CHRNA2, CHRNA5, CHRNA4 HDAC1 202/4885CHRNA7 7/4885CHRNA10 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.